MktsMarkets

DNA X, Inc.
NASDAQ: SONMKey statistics
SONM News
Stories mentioning SONM from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | (44,125) | 16,214 | 11,190 | 16,721 | 15,263 | 15,022 | 11,516 | |
| Cost of Goods Sold | (33,108) | 14,398 | 10,345 | 8,365 | 15,167 | 10,790 | 8,547 | |
| Gross Profit | 0.00 | (11,017) | 1,816 | 845.00 | 8,356 | (183.00) | 4,232 | 2,969 |
| Operating Expenses | ||||||||
| Research & Development | (2,723) | 181.00 | 909.00 | 1,633 | 12,507 | 715.00 | 557.00 | |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 3,618 | (8,837) | 5,796 | 7,577 | 870.00 | (18,538) | 6,608 | 9,439 |
| Operating Income (Loss) | (3,618) | 6,176 | (3,980) | (6,732) | (870.00) | 8,435 | (2,376) | (6,470) |
| Interest Income | ||||||||
| Interest Expense | 131.00 | 374.00 | 339.00 | 161.00 | 71.00 | |||
| Other Expense | 48.00 | (562.00) | (161.00) | (215.00) | 36.00 | 449.00 | (19.00) | (92.00) |
| Pretax Income | (3,928) | 5,005 | (4,663) | (7,336) | (961.00) | 8,872 | (2,395) | (6,579) |
| Tax Provision | 2,538 | (1,507) | 90.00 | 139.00 | 132.00 | (53.00) | 117.00 | 37.00 |
| Net Income (Loss) | 6,340 | (8,887) | (4,753) | (7,475) | 458.00 | (21,614) | (2,512) | (6,616) |
| Earnings Per Share (Basic) | 5.01 | (12.29) | (4.83) | (0.79) | 1.41 | (82.50) | (9.32) | (1.41) |
| Earnings Per Share (Diluted) | 5.01 | (12.29) | (4.83) | (0.79) | 1.41 | (82.50) | (9.32) | (1.41) |
| Weighted Average Shares Outstanding (Basic) | 1,265 | 723.00 | 985.00 | 9,511 | 324.00 | 262.00 | 269.00 | 4,685 |
| Weighted Average Shares Outstanding (Diluted) | 1,265 | 723.00 | 985.00 | 9,511 | 324.00 | 262.00 | 269.00 | 4,685 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SONM
DNA X, Inc. (NASDAQ: SONM) is a stock listed on the Nasdaq Stock Market under the ticker symbol SONM. It last traded at $1.51 (Nov 20, 2026, 2:46 PM ET), down 9.3% on the day. That gives DNA X a market capitalisation of $2.2M and a price-to-earnings ratio of 6.6.
Over the past 52 weeks SONM has traded between $1.57 and $9.54.
Net income for the quarter ended Mar 31, 2026 was $6.3M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | — | $6.3M | — |
| Dec 31, 2025 | -$44.1M | -$8.9M | — |
| Sep 30, 2025 | $16.2M | -$4.8M | -29.3% |
| Jun 30, 2025 | $11.2M | -$7.5M | -66.8% |
From DNA X’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…